Search results for PX-TA1410

Showing 1 – 10 of1products
Enoblituzumab Biosimilar – Anti-CD276, B7-H3 mAb – Research Grade Brand Logo
ID: BAB679443350

Enoblituzumab Biosimilar – Anti-CD276, B7-H3 mAb – Research Grade, ProteoGenix, PX-TA1410

Description of Enoblituzumab Biosimilar - Anti-CD276, B7-H3 mAb - Research Grade General information on Anti-CD276/B7-H3[Homo sapiens] (Enoblituzumab) Monoclonal Antibody Enoblituzumab is investigated for the treatment of B7-H3-expressing Solid Tumors.

Host

Reactivity

Applications

Conjugation

Request a product

Please provide the required information below so that we can quickly source your products.